Article Information
History
- May 13, 2017.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Santiago Ruiz1,
- Pallavi Chandakkar1,
- Haitian Zhao1,
- Julien Papoin2,
- Prodyot K. Chatterjee3,
- Erica Christen1,
- Christine N. Metz3,4,
- Lionel Blanc2,4,
- Fabien Campagne5,6 and
- Philippe Marambaud1,*
- 1Litwin-Zucker Research Center for the Study of Alzheimer’s Disease, The Feinstein Institute for Medical Research, Manhasset, NY, USA
- 2Center for Autoimmune and Musculoskeletal Disorders, The Feinstein Institute for Medical Research, Manhasset, NY, USA
- 3Center for Biomedical Science, The Feinstein Institute for Medical Research, Manhasset, NY, USA
- 4Hofstra Northwell School of Medicine, Hempstead, NY, USA
- 5The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, The Weill Cornell Medical College, New York, NY, USA
- 6Department of Physiology and Biophysics, The Weill Cornell Medical College, New York, NY, USA
- ↵*Correspondence: PMaramba{at}northwell.edu
Posted May 13, 2017.
Tacrolimus rescues endothelial ALK1 loss-of-function signaling and improves HHT vascular pathology
